 NESS ZIONA, Israel, July 20, 2021 GLOBE NEWSWIRE -- Sol-Gel Technologies, Ltd. Nasdaq: SLGL, a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, will report second quarter 2021 financial results on Wednesday, August 4, 2021 at 7:05 AM ET. 